Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology

GC Nguyen, CN Bernstein, A Bitton, AK Chan… - Gastroenterology, 2014 - Elsevier
Background & Aims Guidelines for the management of venous thromboembolism (VTE) from
the American College of Chest Physicians do not address patients with inflammatory bowel …

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

C Kearon, EA Akl - Blood, The Journal of the American Society …, 2014 - ashpublications.org
It takes about 3 months to complete “active treatment” of venous thromboembolism (VTE),
with further treatment serving to prevent new episodes of thrombosis (“pure secondary …

[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis

SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - ejves.com
2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

[HTML][HTML] Thrombophilia testing: a British Society for Haematology guideline

DJ Arachchillage, L Mackillop… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Guidelines Committee and the sounding board of BSH. It was also placed on the members
section of the BSH website for comment. It has also been reviewed by Royal College of …

Diagnosis and management of pulmonary embolism

ST Lapner, C Kearon - Bmj, 2013 - bmj.com
Pulmonary embolism is one manifestation of venous thromboembolism, the other being
deep vein thrombosis. Pulmonary embolism occurs when a deep vein thrombosis breaks …

Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants

CM Hillis, MA Crowther - Thrombosis and Haemostasis, 2015 - thieme-connect.com
The acute phase of venous thromboembolism (VTE) treatment focuses on the prompt and
safe initiation of full-dose anticoagulation to decrease morbidity and mortality. Immediate …

Venous thromboembolism laboratory testing (factor V Leiden and factor II c.* 97G> A), 2018 update: a technical standard of the American College of Medical Genetics …

S Zhang, AK Taylor, X Huang, B Luo, EB Spector… - Genetics in …, 2018 - nature.com
Factor V Leiden and factor II c.* 97G> A (formerly referred to as prothrombin 20210G> A) are
the two most common genetic variants associated with venous thromboembolism (VTE) …

Современные представления об этиологии и патогенезе венозного тромбоза: переосмысление триады Вирхова

КВ Лобастов, ГИ Дементьева, ЛА Лаберко - Флебология, 2019 - elibrary.ru
Статья представляет классический обзор литературы, посвященный анализу
современных сведений об этиологии и патогенезе венозного тромбоза в контексте их …

[HTML][HTML] Isolated thrombosis of right spermatic vein with underlying Factor V Leiden mutation

D Bolat, B Gunlusoy, S Yarimoglu… - Canadian Urological …, 2016 - ncbi.nlm.nih.gov
Spermatic vein thrombosis is a very uncommon clinical entity. Most cases involve the left
side. Herein, we present an unusual case of a young man who presented with spermatic …

Acute pulmonary embolism: risk assessment, risk stratification and treatment options

F Piovella, DI Iosub - The Clinical Respiratory Journal, 2016 - Wiley Online Library
Introduction Pulmonary embolism (PE) is a potentially life‐threatening cardiovascular
emergency with a high mortality rate. Rapid diagnosis and treatment are important in …